Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers

Austin, 2008, A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003, Stat Med, 27, 2037, 10.1002/sim.3150 Bao, 2016, Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians, Health Aff (Millwood), 35, 1045, 10.1377/hlthaff.2015.1673 Beil, 2013, Accuracy of record linkage software in merging dental administrative data sets, J Public Health Dent, 73, 89, 10.1111/j.1752-7325.2012.00343.x Brady, 2014, Prescription drug monitoring and dispensing of prescription opioids, Public Health Rep, 129, 139, 10.1177/003335491412900207 Campbell, 2008, Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a ‘basic’ deterministic algorithm, Health Informatics J, 14, 5, 10.1177/1460458208088855 Chang, 2016, Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis, Drug Alcohol Depend, 165, 1, 10.1016/j.drugalcdep.2016.04.033 Deyo, 2017, Association between initial opioid prescribing patterns and subsequent long-term use among opioid-naïve patients: A statewide retrospective cohort study, J Gen Intern Med, 32, 21, 10.1007/s11606-016-3810-3 Deyo, 2015, Leading a horse to water: Facilitating registration and use of a prescription drug monitoring program, Clin J Pain, 31, 782, 10.1097/AJP.0000000000000180 Dormuth, 2012, Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines, Can Med Assoc J, 184, E852, 10.1503/cmaj.120465 Dowell, 2016, CDC guideline for prescribing opioids for chronic pain—United States, 2016, JAMA, 315, 1624, 10.1001/jama.2016.1464 Fay, 2010, Two-sided exact tests and matching confidence intervals for discrete data, R Journal, 2, 53, 10.32614/RJ-2010-008 Finley, 2017, Evaluating the impact of prescription drug monitoring program implementation: a scoping review, BMC Health Serv Res, 17, 420, 10.1186/s12913-017-2354-5 Gugelmann, 2011, Can prescription drug monitoring programs help limit opioid abuse?, JAMA, 306, 2258, 10.1001/jama.2011.1712 Gwira Baumblatt, 2014, High-risk use by patients prescribed opioids for pain and its role in overdose deaths, JAMA Intern Med, 174, 796, 10.1001/jamainternmed.2013.12711 Hartung, 2017, Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes, Subst Abus Hildebran, 2014, How clinicians use prescription drug monitoring programs: A qualitative inquiry, Pain Med, 15, 1179, 10.1111/pme.12469 Hildebran, 2016, Clinical styles and practice policies: Influence on communication with patients regarding worrisome prescription drug monitoring program data, Pain Med, 17, 2061, 10.1093/pm/pnw019 Irvine, 2014, Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians, J Pain, 15, 747, 10.1016/j.jpain.2014.04.003 Kennedy-Hendricks, 2016, Opioid overdose deaths and Florida's crackdown on pill mills, Am J Public Health, 106, 291, 10.2105/AJPH.2015.302953 Leichtling, 2017, Clinicians' use of prescription drug monitoring programs in clinical practice and decision-making, Pain Med, 18, 1063 Meara, 2016, State legal restrictions and prescription-opioid use among disabled adults, N Engl J Med, 375, 44, 10.1056/NEJMsa1514387 Nam, 2017, State prescription drug monitoring programs and fatal drug overdoses, Am J Manag Care, 23, 297 Okie, 2010, A flood of opioids, a rising tide of deaths, N Engl J Med, 363, 1981, 10.1056/NEJMp1011512 O'Kane, 2016, Preparing a prescription drug monitoring program data set for research purposes, Pharmacoepidemiol Drug Saf, 25, 993, 10.1002/pds.4039 Oregon Health Authority, Center for Prevention & Health Promotion, Injury & Violence Prevention Section Pardo, 2016, Do more robust prescription drug monitoring programs reduce prescription opioid overdose?, Addiction, 112, 1773, 10.1111/add.13741 Patrick, 2016, Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates, Health Aff (Millwood), 35, 1324, 10.1377/hlthaff.2015.1496 Paulozzi, 2011, Vital signs: Overdoses of prescription opioid pain relievers, United States, 1999–2008, MMWR Morb Mortal Wkly Rep, 60, 1487 Paulozzi, 2011, Prescription drug monitoring programs and death rates from drug overdose, Pain Med, 12, 747, 10.1111/j.1526-4637.2011.01062.x Paulozzi, 2012, A history of being prescribed controlled substances and risk of drug overdose death, Pain Med, 13, 87, 10.1111/j.1526-4637.2011.01260.x Perrone, 2012, Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012, J Med Toxicol, 8, 341, 10.1007/s13181-012-0250-2 Rudd, 2016, Increases in drug and opioid overdose deaths—United States, 2000–2014, MMWR Morb Mortal Wkly Rep, 64, 1378, 10.15585/mmwr.mm6450a3 Rutkow, 2015, Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access, Health Aff (Millwood), 34, 484, 10.1377/hlthaff.2014.1085 Young, 2017, The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida, Int J Emerg Med, 10, 16, 10.1186/s12245-017-0140-0